Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  title={Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries},
  author={Hyuna Sung and Jacques Ferlay and Rebecca L. Siegel and Mathieu Laversanne and Isabelle Soerjomataram and Ahmedin Jemal and Freddie Bray},
  journal={CA: A Cancer Journal for Clinicians},
  pages={209 - 249}
This article provides an update on the global cancer burden using the GLOBOCAN 2020 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer. Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. Female breast cancer has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated… 
Cancer statistics for the year 2020: An overview
Our study briefly reviews the data sources and methods used in compiling the International Agency for Research on Cancer (IARC) GLOBOCAN cancer statistics for the year 2020 and summarises the main
The Burden of Cancer, Government Strategic Policies, and Challenges in Pakistan: A Comprehensive Review
The current cancer epidemiology in Pakistan is presented and current cancer risk factors, causes, and the strategies and policies of the country against cancer are summarized to better understand cancer basis.
Epidemiology of stomach cancer
Stomach cancer is one of the most lethal malignant tumors, with a five-year survival rate of around 20%, and ranks as the fourth leading cause of cancer deaths in both genders combined.
An updated profile of the cancer burden, patterns and trends in Latin America and the Caribbean
Cancer incidence and mortality in Poland in 2019
To offer the most important epidemiological indicators of malignant neoplasms in Poland for the year 2019, the Polish National Cancer Registry received information on almost 171.2 thousand new cancer cases and 100.3 thousand cancer deaths in 2019.
Global Burden And Trends of Lung Cancer Incidence And Mortality
The burden of lung cancer is still not optimistic, especially in developing countries like China, so further strengthen health education, accelerate the establishment of tobacco control policies and regulations, and improve the early cancer screening awareness to curb the future lung cancer burden.
Cancer Incidence and Mortality in Asian Countries: A Trend Analysis
There was a substantial burden of cancer incidence and mortality in Asia and although there was a decreasing trend in cancer mortality, its incidence had been increasing especially among female and younger populations.
Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050
  • Rajesh Sharma
  • Medicine
    International Journal of Clinical Oncology
  • 2022
Both ASIR and ASMR were positively correlated with country-level tobacco smoking prevalence and human development index (HDI), whereas MIR exhibited a negative correlation with HDI.
Prostate cancer mortality and costs of prostate surgical procedures in the Brazilian public health system
The main focus of this study is to present a description of data concerning PCa mortality, diagnosed cases, and the costs of prostate surgical procedures in the SUS based on two public databases.
The global, regional and national burden of stomach cancer and its attributable risk factors from 1990 to 2019
In 2019, most of the global numbers of incidence, death and DALYs were higher among males than females, and a considerable burden of stomach cancer was attributable to smoking and a high-sodium diet.


Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
The sources and methods used in compiling the cancer statistics in 185 countries are reviewed, and uncertainty intervals are now provided for the estimated sex‐ and site‐specific all‐ages number of new cancer cases and cancer deaths.
European cancer mortality predictions for the year 2019 with focus on breast cancer.
  • M. Malvezzi, G. Carioli, E. Negri
  • Medicine, Political Science
    Annals of oncology : official journal of the European Society for Medical Oncology
  • 2019
Favourable trends for major neoplasms are predicted to continue, except for pancreatic cancer, which is likely due to population ageing, however, the number of breast cancer deaths is not declining.
Global Burden of 5 Major Types Of Gastrointestinal Cancer.
There was a uniform decrease in gastric cancer incidence but an increasing incidence of colorectal cancer in formerly low-incidence regions over the studied time period, and slight increases in incidence of liver and pancreatic cancer in some high-income regions.
Cancer statistics, 2019
The overall cancer death rate dropped continuously from 1991 to 2016 by a total of 27%, translating into approximately 2,629,200 fewer cancer deaths than would have been expected if death rates had remained at their peak.
Cancer in Africa 2012
With the number of annual cancer cases and deaths likely to increase by at least 70% by 2030, there is a pressing need for a coordinated approach to improving the extent and quality of services for cancer control in Africa, and better surveillance systems with which they can be planned and monitored.
Colorectal cancer statistics, 2020
Progress against CRC can be accelerated by increasing access to guideline‐recommended screening and high‐quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle‐aged adults.
Breast cancer statistics, 2019
Breast cancer was the leading cause of cancer death in women in four Southern and two Midwestern states among blacks and in Utah among whites during 2016‐2017, and could be accelerated by expanding access to high‐quality prevention, early detection, and treatment services to all women.
More deaths from pancreatic cancer than breast cancer in the EU by 2017
Although strategies may emerge in the near future that will enhance the prospects of improving the very poor five-year survival from pancreatic cancer, coordinated efforts are necessary to reduce the foreseeable high mortality burden of disease within the EU.